サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1536677

軽度認知障害市場：適応症別、疾患タイプ別、年齢層別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測

Mild Cognitive Impairment Market, By Indication, By Disease Type, By Age Group, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032

出版日
ページ情報
英文 311 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
軽度認知障害市場：適応症別、疾患タイプ別、年齢層別、国別、地域別：産業分析、市場規模、市場シェア、2024年～2032年予測
出版日: 2024年08月04日
発行: AnalystView Market Insights
ページ情報: 英文 311 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

軽度認知障害市場規模は2023年に19億8,021万米ドルとなり、2024年から2032年にかけてCAGR 5.24％で拡大

軽度認知障害市場-市場力学

高齢者人口の増加と診断方法の進歩が市場の需要を促進すると予想される

MCIやその他の認知障害の有病率は、人口の増加とともに増加します。高齢燃料の増加により、診断ツール、治療、管理戦略が求められます。ヘルスケア提供者や一般市民の間でMCIに対する認識と理解が高まっています。診断方法の進歩や教育的努力の増加は、発見率の向上やその後の介入需要の増加に寄与しています。

さらに、認知健康および関連分野へのヘルスケア支出の増加は、MCI関連製品・サービスの需要を促進しています。政府や民間部門は、認知障害に対するより良いケアソリューションに投資しています。認知トレーニングアプリ、遠隔医療、ウェアラブルデバイスなどのデジタルヘルス技術の台頭は、MCIの管理とモニタリングを強化します。テクノロジーは患者の関与を高め、治療や調査に新たな道を提供します。MCIの症状管理や進行抑制を目的とした薬剤の開発は、市場力学に影響を与えます。新しい治療薬と臨床試験は医薬品分野の成長に寄与します。

軽度認知障害市場-主要インサイト

当社リサーチアナリストの分析によると、世界市場は予測期間（2024-2032年）に約524%のCAGRで毎年成長すると推定されます。

適応症のセグメンテーションに基づくと、アルツハイマー病（AD）セグメントは、アルツハイマー病の有病率の増加により、2023年に最大の市場シェアを示すと予測されました。

疾患タイプ別では、高齢者における有病率の高さから、2023年の疾患タイプは無記名型がトップでした。

年齢層別では、アルツハイマー病や血管性認知症などの治療ニーズが高いことから、2023年には老年者層が主要な年齢層となった。

地域別では、主にアルツハイマー病の高い発症率により、北米が2023年の主要な収益源でした。

軽度認知障害市場-セグメンテーション分析：

軽度認知機能障害の世界市場は、適応症、疾患タイプ、年齢層、地域に基づいてセグメント化されます。

適応症に基づき、市場は5つのカテゴリーに分けられる：アルツハイマー型認知症、血管性認知症、レビー小体型認知症、パーキンソン病認知症、その他。アルツハイマー型認知症が市場を独占しています。認知症の治療には軽度の認知機能障害が必要であり、これがセグメントの成長に寄与しています。

市場は疾患タイプにより、健忘性MCIと非健忘性MCIの2つに分類されます。国内MCI市場が最も大きなシェアを占めると予測されています。健忘性軽度認知障害は記憶の欠落を示し、それほど深刻な状態ではないが、高齢者の間で増加しています。

市場は、年齢層によって小児、成人、老人の3つに分類されます。老年セグメントが市場を独占しており、予測期間中も高い優位性を維持すると予想されます。アルツハイマー病に罹患し、軽度認知障害問題を抱える高齢者が、このセグメントの需要を押し上げています。

軽度認知障害市場-地理的洞察

地域的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの各地域に広がっています。北米が軽度認知障害市場を独占しています。米国は高齢者人口が多く、増加傾向にあるため、MCIの有病率が高いです。早期診断と治療をサポートする高度なヘルスケアインフラとともに、研究開発への投資も盛んです。アジアでは、日本は高齢者の割合が高く、認知障害に関する研究開発のリーダーです。日本では、MCIを管理するためのヘルスケアサービスが確立されています。

軽度認知障害市場-競合情勢：

軽度認知障害市場の競争は中程度です。市場に参入している企業は、MCIおよび関連する認知障害の管理を目的とした薬剤や治療法の開発に携わっています。バイオジェンやイーライリリーのような企業は、アルツハイマー病やMCIと重複する可能性のある他の神経変性疾患の治療法を開発しています。強力な研究開発パイプラインを持つ企業は、治療や診断を進める上で極めて重要です。バイオマーカーや医薬品開発におけるイノベーションは、競合要因として重要です。

目次

第1章 軽度認知障害市場概要

  • 調査範囲
  • 市場推定年

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 軽度認知障害の主要市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 軽度認知障害産業研究

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しマッピング
  • 規制枠組み分析

第5章 軽度認知障害市場： COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19後の影響分析

第6章 軽度認知障害市場情勢

  • 軽度認知障害市場シェア分析、2023年
  • 主要メーカー別内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 軽度認知障害市場- 適応症別

  • 概要
    • セグメントシェア分析（適応症別）
    • アルツハイマー病認知症
    • 血管性認知症
    • レビー小体型認知症
    • パーキンソン病認知症
    • その他

第8章 軽度認知障害市場- 疾患タイプ別

  • 概要
    • 疾病タイプ別セグメントシェア分析
    • 健忘性MCI
    • 非健忘性MCI

第9章 軽度認知障害市場- 年齢層別

  • 概要
    • 年齢層別セグメントシェア分析
    • 子供
    • 成人
    • 高齢者

第10章 軽度認知障害市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- 軽度認知障害業界

  • 競争ダッシュボード
  • 企業プロファイル
    • Eli Lilly and Company
    • Biogen Inc.
    • Roche Holding AG
    • Axovant Gene Therapies Ltd.
    • GE Healthcare
    • Philips Healthcare
    • Neurotrack Technologies
    • Cogstate Ltd.
    • Lumosity Inc.
    • Alzheimer's Drug Discovery Foundation（ADDF）
    • AstraZeneca
    • Novartis International AG
    • Takeda Pharmaceutical Company Limited
    • Denali Therapeutics Inc.
    • HappyNeuron
    • Others

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Mild Cognitive Impairment Market: Indication Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Indication
  • TABLE Global Mild Cognitive Impairment Market, by Indication 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Disease Type Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Disease Type
  • TABLE Global Mild Cognitive Impairment Market, by Disease Type 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Age Group Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Age Group
  • TABLE Global Mild Cognitive Impairment Market, by Age Group 2019-2032 (USD Million)
  • TABLE Mild Cognitive Impairment Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Mild Cognitive Impairment Market, by Region 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE North America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Europe Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Asia Pacific Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Latin America Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Indication, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Disease Type, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Mild Cognitive Impairment Market, by Age Group, 2019-2032 (USD Million)

List of Figures

  • FIGURE Mild Cognitive Impairment Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2023
  • FIGURE Indication segment market share analysis, 2023 & 2032
  • FIGURE Indication segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Disease Type segment market share analysis, 2023 & 2032
  • FIGURE Disease Type segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Age Group segment market share analysis, 2023 & 2032
  • FIGURE Age Group segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Regional segment market share analysis, 2023 & 2032
  • FIGURE Regional segment market size forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE North America Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Europe Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Asia Pacific Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Latin America Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market share and leading players, 2023
  • FIGURE North America market share analysis by country, 2023
  • FIGURE U.S. Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Canada Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Europe Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Germany Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Spain Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Italy Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE France Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE UK Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Russia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Netherlands Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Sweden Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Poland Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of the Europe Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Asia Pacific Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE India Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE China Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Japan Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE South Korea Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Australia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Thailand Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Indonesia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Philippines Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of APAC Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Latin America Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Brazil Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Mexico Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Argentina Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Colombia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of LATAM Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Middle East and Africa Mild Cognitive Impairment Market share analysis by country, 2023
  • FIGURE Saudi Arabia Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE United Arab Emirates Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Israel Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Turkey Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Algeria Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Egypt Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
  • FIGURE Rest of MEA Mild Cognitive Impairment Market size, forecast and trend analysis, 2019 to 2032 (USD Million)
目次
Product Code: ANV3526

REPORT HIGHLIGHT

Mild Cognitive Impairment Market size was valued at USD 1,980.21 Million in 2023, expanding at a CAGR of 5.24% from 2024 to 2032.

Mild Cognitive Impairment (MCI) is a kind of disease characterized by noticeable changes in cognitive function that are greater than expected for a person's age but not severe enough to interfere significantly with daily life. People with MCI might experience difficulties with memory, language, thinking, or judgment that are noticeable to themselves or others.

Mild Cognitive Impairment Market- Market Dynamics

The growing older population and advancement in diagnostic methods are expected to propel market demand

The prevalence of MCI and other cognitive disorders increases as the population rises. The growing number of older fuels demand diagnostic tools, treatments, and management strategies. There is a greater awareness and understanding of MCI among healthcare providers and the public. Advances in diagnostic methods and increased educational efforts contribute to higher detection rates and subsequent demand for interventions.

Further, increased healthcare spending on cognitive health and related areas drives demand for MCI-related products and services. Governments and private sectors are investing in better care solutions for cognitive disorders. The rise of digital health technologies, such as cognitive training apps, telemedicine, and wearable devices, enhances the management and monitoring of MCI. Technology improves patient engagement and provides new avenues for treatment and research. The development of drugs aimed at managing symptoms or modifying the progression of MCI influences market dynamics. New therapeutic agents and clinical trials contribute to growth in the pharmaceutical sector.

Mild Cognitive Impairment Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 524% over the forecast period (2024-2032)

Based on Indication segmentation, the Alzheimer's disease (AD) segment was predicted to show maximum market share in the year 2023, owing to the increased prevalence of Alzheimer's disease.

Based on Disease Type segmentation, the amnestic segment was the leading Disease Type in 2023, due to high prevalence among older adults.

Based on Age Group segmentation, the geriatric segment was the leading Age Group in 2023, owing to the high need for treatment of Alzheimer's, vascular dementia, etc.

On the basis of region, North America was the leading revenue generator in 2023, mainly due to the high incidence of Alzheimer's disease.

Mild Cognitive Impairment Market- Segmentation Analysis:

The Global Mild Cognitive Impairment Market is segmented on the basis of Indication, Disease Type, Age Group, and Region.

The market is divided into five categories based on Indication: Alzheimer's Disease, Vascular Dementia, Lewy Body Dementia, Parkinson's Disease Dementia, and others. The Alzheimer's Disease Dementia segment dominates the market. Mild cognitive impairment is needed for dementia cure which is contributing to segment growth.

The market is divided into two categories based on Disease Type: amnestic MCI and non-amnestic MCI. The amnestic MCI segment is projected to hold the largest share of the market. Amnestic mild cognitive impairment indicates memory deficiency and is not so severe condition but is growing among old age people.

The market is divided into three categories based on Age Group: child, adult, and geriatric. The geriatric segment dominates the market and is expected to maintain its high dominance during the forecast period. Older age people suffering from Alzheimer's and having mild cognitive impairment issue are boosting segment demand.

Mild Cognitive Impairment Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. North America dominates the Mild Cognitive Impairment market. The U.S. has a large and growing elderly population, contributing to a high prevalence of MCI. There is significant investment in research and development, along with advanced healthcare infrastructure that supports early diagnosis and treatment. In Asia, Japan has a high proportion of elderly individuals and is a leader in research and development related to cognitive impairments. The country has well-established healthcare services for managing MCI.

Mild Cognitive Impairment Market- Competitive Landscape:

The Mild Cognitive Impairment market is moderately competitive. The companies in the market are involved in developing drugs and therapies aimed at managing MCI and related cognitive disorders. Companies like Biogen and Eli Lily are developing treatments for Alzheimer's disease and other neurodegenerative conditions that can overlap with MCI. Companies with strong research and development pipelines are crucial in advancing treatments and diagnostics. Innovation in biomarkers and drug development are key competitive factors.

Recent Developments:

In July 2022, La Roche received FDA approval for the Elecsys Amyloid Plasma panel in the treatment of Alzheimer's disease.

In 2022, Teva Pharmaceuticals launched a generic Revlimid capsule for mild cognitive impairment care.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET KEY PLAYERS

  • Eli Lilly and Company
  • Biogen Inc.
  • Roche Holding AG
  • Axovant Gene Therapies Ltd.
  • GE Healthcare
  • Philips Healthcare
  • Neurotrack Technologies
  • Cogstate Ltd.
  • Lumosity Inc.
  • Alzheimer's Drug Discovery Foundation (ADDF)
  • AstraZeneca
  • Novartis International AG
  • Takeda Pharmaceutical Company Limited
  • Denali Therapeutics Inc.
  • HappyNeuron
  • Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY INDICATION- MARKET ANALYSIS, 2019-2032

  • Alzheimer's Disease
  • Vascular Dementia
  • Lewy Body Dementia
  • Parkinson Disease Dementia
  • Others

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY DISEASE TYPE- MARKET ANALYSIS, 2019-2032

  • Amnestic MCI
  • Non-amnestic MCI

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY AGE GROUP- MARKET ANALYSIS, 2019-2032

  • Child
  • Adult
  • Geriatric

GLOBAL MILD COGNITIVE IMPAIRMENT MARKET, BY REGION- MARKET ANALYSIS, 2019-2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Mild Cognitive Impairment Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Mild Cognitive Impairment Market Snippet by Indication
    • 2.1.2. Mild Cognitive Impairment Market Snippet by Disease Type
    • 2.1.3. Mild Cognitive Impairment Market Snippet by Age Group
    • 2.1.4. Mild Cognitive Impairment Market Snippet by Country
    • 2.1.5. Mild Cognitive Impairment Market Snippet by Region
  • 2.2. Competitive Insights

3. Mild Cognitive Impairment Key Market Trends

  • 3.1. Mild Cognitive Impairment Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Mild Cognitive Impairment Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Mild Cognitive Impairment Market Opportunities
  • 3.4. Mild Cognitive Impairment Market Future Trends

4. Mild Cognitive Impairment Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Mild Cognitive Impairment Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Mild Cognitive Impairment Market Landscape

  • 6.1. Mild Cognitive Impairment Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Mild Cognitive Impairment Market - By Indication

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Indication, 2024 & 2032 (%)
    • 7.1.2. Alzheimer's Disease Dementia
    • 7.1.3. Vascular Dementia
    • 7.1.4. Lewy Body Dementia
    • 7.1.5. Parkinson Disease Dementia
    • 7.1.6. Others

8. Mild Cognitive Impairment Market - By Disease Type

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Disease Type, 2024 & 2032 (%)
    • 8.1.2. Amnestic MCI
    • 8.1.3. Non-amnestic MCI

9. Mild Cognitive Impairment Market - By Age Group

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Age Group, 2024 & 2032 (%)
    • 9.1.2. Child
    • 9.1.3. Adult
    • 9.1.4. Geriatric

10. Mild Cognitive Impairment Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Mild Cognitive Impairment Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Mild Cognitive Impairment Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Mild Cognitive Impairment Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Mild Cognitive Impairment Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Mild Cognitive Impairment Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Indication, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Disease Type, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Age Group, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Mild Cognitive Impairment Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Eli Lilly and Company
    • 11.2.2. Biogen Inc.
    • 11.2.3. Roche Holding AG
    • 11.2.4. Axovant Gene Therapies Ltd.
    • 11.2.5. GE Healthcare
    • 11.2.6. Philips Healthcare
    • 11.2.7. Neurotrack Technologies
    • 11.2.8. Cogstate Ltd.
    • 11.2.9. Lumosity Inc.
    • 11.2.10. Alzheimer's Drug Discovery Foundation (ADDF)
    • 11.2.11. AstraZeneca
    • 11.2.12. Novartis International AG
    • 11.2.13. Takeda Pharmaceutical Company Limited
    • 11.2.14. Denali Therapeutics Inc.
    • 11.2.15. HappyNeuron
    • 11.2.16. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us